Bristol-Myers Squibb Co. (BMY)

Sanjiv523 (< 20) Submitted: 8/18/06 2:32 AM : Start Price: $20.06 BMY Score: 10.65

This company has one of the best pipelines in the business. The Plavix dispute has cast a temporary cloud over what might be one of the best future cash flow drivers in the market. The loss of the Plavix patent will take a bite out of profits for the...

Report this Post Replies: 1 | Reply | Permalink

phoggy (< 20) Submitted: 12/08/06 8:28 AM : Start Price: $23.58 BMY Score: 1.98

Since falling from 52 bucks in Mar '02 to 21 bucks in Jul '02, Bristol-Myers has been pretty much locked into a trading range between 20 and 25 dollars. It made a mini-move in the past few days and may just be ready to move out of that range.

Report this Post Replies: 0 | Reply | Permalink

NetscribePhrmtcl (94.54) Submitted: 11/28/06 7:38 AM : Start Price: $22.96 BMY Score: 2.59

Blockbuster Plavix breathes a sigh of relief! Bristol-Myers Squibb is engaged in the discovery, development, licensing, and marketing of pharmaceutical and other health care products in the United States and other countries across the world.

Plavix...

Report this Post Replies: 2 | Reply | Permalink

jim001x (49.73) Submitted: 3/23/08 8:23 PM : Start Price: $20.89 BMY Score: 8.62

At 21.46 BMY is trading close to its 52 week low with a 5.78% DY.


Last Morningstar fair value estimates were $26 and 23. S&P has a $26 target price.


BMY Was recommended by Chuck Carlson with Quadrix 1st of the year and gon...

Report this Post Replies: 1 | Reply | Permalink

proudfather (32.78) Submitted: 6/11/08 6:09 PM : Start Price: $19.76 BMY Score: 15.65

Bristol Myers is way over-sold at $20. It has not traded below $20 since 1996 and has met resistance at the $20 level on numerous occasions since then. Basic fundamentals are sound. Price/Sales could be a bit lower, but I think the "price" is not ...

Report this Post Replies: 1 | Reply | Permalink

1firebird (20.54) Submitted: 8/26/06 3:05 AM : Start Price: $20.29 BMY Score: 9.00

change in CEO &/or ownership

Report this Post Replies: 0 | Reply | Permalink

xthecritic (98.10) Submitted: 12/17/07 2:38 PM : Start Price: $27.22 BMY Score: -3.51

This is a sector play. Drug manufacturers have been and will continue to outperform the market in the next 12-18 months as we deal with economic weakness. I like the sector overall after several years of pressure from products coming off patent and...

Report this Post Replies: 0 | Reply | Permalink

martynanasi (99.24) Submitted: 11/14/06 1:15 PM : Start Price: $22.62 BMY Score: 4.45

Bristol Myers has had many issues over the last five years. Problems with debt load, production facilites, patent expiration, lack of new drug pipeline etc. At these prices BMY is a good choice for a large pharma. Especially when compared to large ri...

Report this Post Replies: 0 | Reply | Permalink

ahobbs (81.68) Submitted: 12/15/07 1:28 AM : Start Price: $27.26 BMY Score: -8.63

A few publications (Money Mag and Smart Money Mag) have been recommending Johnson & Johnson (JNJ) recently as good stock to own in case of a recession; However, JNJ doesn't have the projected earnings growth I typically like to see in the stocks I ow...

Report this Post Replies: 0 | Reply | Permalink

manchesteruk (< 20) Submitted: 10/05/06 3:30 AM : Start Price: $22.82 BMY Score: -0.87

only potential M&A make this stock attractive

Report this Post Replies: 1 | Reply | Permalink